NuGen Medical Devices Inc. (NGMDF)
OTCMKTS · Delayed Price · Currency is USD
0.0242
0.00 (0.00%)
At close: Feb 9, 2026

NuGen Medical Devices Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
51218310-
Market Cap Growth
-66.02%-34.91%533.68%-72.01%--
Enterprise Value
151922715-
Last Close Price
0.020.050.090.03--
PS Ratio
11.8116.7772.0725.3593.73-
PB Ratio
-0.80-2.99-11.59-1.717.78-
EV/Sales Ratio
35.3526.5989.5266.22134.06-
Debt / Equity Ratio
-2.12-3.14-3.83-3.273.38-10.26
Net Debt / Equity Ratio
-1.62-1.91-3.60-3.222.33-9.87
Net Debt / EBITDA Ratio
-4.31-2.39-1.00-1.72-0.75-3.07
Net Debt / FCF Ratio
-2.54-2.30-1.10-3.41-0.94-4.88
Asset Turnover
0.050.100.050.020.010.01
Inventory Turnover
0.781.841.171.194.02-
Quick Ratio
3.675.440.250.221.670.04
Current Ratio
4.185.840.400.331.740.66
Return on Equity (ROE)
-----1472.02%-
Return on Assets (ROA)
-19.05%-32.49%-72.92%-38.18%-30.93%-21.44%
Return on Capital Employed (ROCE)
-43.30%-44.60%-220.20%-93.60%-76.10%-53.80%
Earnings Yield
-30.44%-30.85%-39.20%-144.41%-55.08%-
FCF Yield
-79.24%-27.89%-28.13%-55.20%-31.77%-
Buyback Yield / Dilution
-7.48%-27.89%-86.08%-31.20%-26.95%-128.66%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.